Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets.

Petrusca, Daniela N; Lee, Kelvin P; Galson, Deborah L

Petrusca, Daniela N; Lee, Kelvin P; Galson, Deborah L.

Afiliación

Petrusca DN; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.
Lee KP; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.
Galson DL; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, United States.

Front Oncol ; 12: 925807, 2022.

Article en En | MEDLINE | ID: mdl-35756630

Palabras clave

bone marrow microenvironment; drug-resistance; multiple myeloma; sphingolipids; therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google